Booting Earth Optimization System
Thank you for your patience. Your civilization is very important to us.
Low-dose Aspirin
Treatment for Maternal hypertensive disorders
Typical Dosage: 81-150 mg daily
Effectiveness
80%
Safety Score
81%
Clinical Trials
100
Participants
30K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
81
DangerousModerateSafe
Treatment Details
Dosage Range
81-150 mg daily
Time to Effect
Weeks-months (preventive effect)
Treatment Duration
12-16 weeks gestation until delivery
Evidence Quality
HIGHNumber Needed to Treat (NNT)
30(Treat 30 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
1000(Treat 1000 patients to see 1 additional serious adverse event)
Confidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$20
Monitoring:$25
Side Effect Mgmt:$25
Total Annual:$70
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$5,000/QALY
QALYs Gained
0.005
Outcome-Based Costs
Cost per Responder
$467
Low-dose Aspirin Outcomes
for Maternal hypertensive disorders
Efficacy Outcomes
Overall Effectiveness
+80%
Response Rate
+15%
Common Side Effects
Minor bleeding (nosebleeds, bruising)
+7%
Gastrointestinal upset
+3%
Major bleeding
+0.1%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov